Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Communication Disorders × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 147 Breast Neoplasms 141 Prostatic Neoplasms 85 Lung Neoplasms 73 Colorectal Neoplasms 53 Brain Neoplasms 31 Pancreatic Neoplasms 30 Motor Activity 28 Ovarian Neoplasms 27 Head and Neck Neoplasms 27 Uterine Cervical Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Carcinoma, Non-Small-Cell Lung 21 Glioblastoma 20 Anxiety Disorders 20 Neoplasm Metastasis 19 Depression 18 Glioma 17 Colonic Neoplasms 17 Pain 16 Melanoma 16 Carcinoma, Renal Cell 16 Carcinoma, Hepatocellular 16 Urinary Bladder Neoplasms 14 Rectal Neoplasms 14 Sarcoma 13 Lymphoma, Follicular 12 Leukemia, Myeloid, Acute 12 Hematologic Neoplasms 12 Gastrointestinal Neoplasms 12

Interventions

Speech Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

13 enrolled 8 charts

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡